Gelteq Limited (GELS) Stock

NASDAQ: GELSHealthcare company in the specialty & generic drug manufacturers industry, based in Clayton, VIC.

Gelteq stock price chart

GELS interactive chart →

GELS stock quote & key statistics

Gelteq earnings per share

Income →
Earnings per share

Gelteq revenue & net income

Income →
RevenueNet income

Gelteq annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2025$165,645-$6.6M—
FY2024$0-$3.5M—
FY2023$79,843-$3.5M—
FY2022$147,536-$3.4M—
FY2021$0-$648,921—

Fiscal year ending June 30. Source: company filings via EODHD.

About Gelteq Limited

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.

Gelteq stock FAQ

What is the Gelteq stock ticker symbol?

Gelteq Limited trades on the NASDAQ under the ticker symbol GELS.

What sector and industry is Gelteq in?

Gelteq Limited is classified in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.

How many employees does Gelteq have?

Gelteq Limited has about 7 full-time employees.

What were Gelteq's revenue and earnings last fiscal year?

Gelteq reported revenue of $165,645 and net income of -$6.6M in fiscal 2025.

When did Gelteq go public?

Gelteq stock began trading on October 29, 2024.

Drug Manufacturers - Specialty & Generic stocks

All Healthcare stocks →